Provided by Tiger Trade Technology Pte. Ltd.

Fidelity MSCI Health Care Index ETF

80.40
-0.0600-0.07%
Volume:69.40K
Turnover:5.59M
Market Cap:3.38B
PE:- -
High:81.19
Open:81.03
Low:80.21
Close:80.46
52wk High:85.46
52wk Low:64.30
Shares:42.00M
Float Shares:42.00M
Volume Ratio:0.36
T/O Rate:0.17%
Dividend:1.02
Dividend Rate:1.27%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

AbbVie Says Atogepant Met Primary, Secondary Endpoints in Phase 3 Menstrual Migraine Study

MT Newswires Live
·
Yesterday

AbbVie’s atogepant shows positive Phase 3 results in menstrual migraine

TIPRANKS
·
Yesterday

Abbvie - Atogepant Safety Results Consistent with Known Profile; no New Safety Signals

THOMSON REUTERS
·
Yesterday

Abbvie - Atogepant Meets Primary and All Eight Ranked Secondary Endpoints in Phase 3 Luna Study

THOMSON REUTERS
·
Yesterday

Abbvie Extends Migraine Leadership with Positive Phase 3 Atogepant Results in Menstrual Migraine

THOMSON REUTERS
·
Yesterday

Abbvie - Atogepant Shows Significant Improvements Across Multiple Endpoints Versus Placebo

THOMSON REUTERS
·
Yesterday

Johnson & Johnson receives CE Marking for ACUVUE OASYS MAX

TIPRANKS
·
Yesterday

Johnson & Johnson Receives Ce Marking for Acuvue Oasys Max Reusable Contact Lenses

THOMSON REUTERS
·
Yesterday

HSBC Adjusts Price Target on Eli Lilly and Co. to $940 From $850, Keeps Reduce Rating

MT Newswires Live
·
Yesterday

Bank of America Reveals 5.22% Indirect Stake in Qiagen

TIPRANKS
·
Yesterday

'Cut Points' for 2027 Medicare Advantage Plans Look Neutral to Positive, Analysts Say

Reuters
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Why Is UnitedHealth Stock (UNH) Down on Wednesday, 9/9/2026?

TIPRANKS
·
Yesterday

Merck Price Target Raised to $161.00/Share from $127.00 by Leerink Partners

Dow Jones
·
Yesterday

Top Midday Stories: Meta Launches Muse Personal AI Agent; Dow Said to Consider Exiting $20 Billion Chemicals JV With Saudi Aramco

MT Newswires Live
·
Sep 09

UnitedHealth Falls; Cites Pressure in Commercial Business

Reuters
·
Sep 09

Tyra Biosciences Stock Plunges 22% as Bladder Cancer Pill Fails to Impress

Dow Jones
·
Sep 09

Abbvie Exec Says Strong Balance Sheet and Long Growth Runway Allow Company to Consider Both Early- and Late-Stage Business Development Opportunities - Conf Call

THOMSON REUTERS
·
Sep 09

Abbvie Exec Says Expects Approval of Subcutaneous Crohn's Disease Treatment in Q4 - Conf Call

THOMSON REUTERS
·
Sep 09

UnitedHealth Shares Down 5.2%

THOMSON REUTERS
·
Sep 09